Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 12, 1999, Pages 2873-2876

  Schulin T ^b   Thauvin Eliopoulos, C ^b   Moellering Jr , R C ^b   Eliopoulos, G M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPEREZOLID; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

ABDOMINAL ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

EID: 0344146475     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.12.2873     Document Type: Article

References (26)

1. Andes, D., M. L. Van Ogtrop, and W. A. Craig. 1998 Pharmacodynamic activity of a new oxazolidinone, linezolid, in an animal infection model, abstr. A-9. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
2. Bostic, G., M. B. Perri, L. A. Thai, and M. J. Zervos. 1998. Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci. Diagn. Microbiol. Infect. Dis. 30:109-112.
3. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, P. R. Manninen, D. A. Ulaniwicz, S. A. Garmon, K. C. Grega, S. K. Hendges, D. S. Toops, C. W. Ford, and G. E. Zurenko. 1996. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J. Med. Chem. 39:673-679.
4. Burnett, R. J., D. C. Haverstock, E. P. Dellinger, H. H. Reinhart, J. M. Bohnen, O. D. Rotstein, S. B. Vogel, and J. S. Solomkin. 1995. Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 118:716-721.
5. Chiba, K., K. L. Feenstra, J. G. Slatter, P. T. Daley-Yates, J. N. Duncan, P. E. Fagerness, M. R. Howard, I. J. Martin, N. Ozawa, B. J. Passingham, H. G. Parks, G. W. Peng, R. J. Simmonds. W. Speed, D. Yallop, and S. Yamazaki. 1998. Absorption, distribution, metabolism, and excretion of the oxazolidinone antibiotic linezolid (PNU-100766) in the Sprague-Dawley rat, abstr. A-123. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Eliopoulos, G. M. 1996. Antibiotic resistance in Enterococcus spp.: an update, p. 21-51. In J. S. Remington and M. N. Swartz (ed.), Current clinical topics in infectious diseases, vol. 16. Blackwell Sciences, Cambridge, Mass.
7. Eliopoulos, G. M., C. B. Wennersten, H. S. Gold, and R. C. Moellering, Jr. 1996. In vitro activities of new oxazolidinone antimicrobial agents against enterococci. Antimicrob. Agents Chemother. 40:1745-1747.
8. Ford, C. W., J. C. Hamel, D. M. Wilson, J. K. Moerman, D. Stapert, R. J. Yancey, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40:1508-1513.
9. Gardner, P., D. H. Smith, H. Beer, and R. C. Moellering, Jr. 1969. Recovery of resistance [R] factors from a drug-free community. Lancet ii:774-776.
10. Grayson, M. L., C. Thauvin-Eliopoulos, G. M. Eliopoulos, J. D. C. Yao, D. V. DeAngelis, L. Walton, J. L. Wooley, and R. C. Moellering, Jr. 1990. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 34:1792-1794.
11. Handwerger, S., M. J. Pucci, and A. Kolokathis. 1990. Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228. Antimicrob. Agents Chemother. 34:358-360.
12. Hindes, R. G., S. H. Willey, G. M. Eliopoulos, L. B. Rice, C. T. Eliopoulos, B. E. Murray, and R. C. Moellering, Jr. 1989. Treatment of experimental endocarditis caused by a β-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin. Antimicrob. Agents Chemother. 33:1019-1022.
13. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
14. Lin, A. H., R. W. Murray, T. J. Vidmar, and K. R. Marotti. 1997. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with chloramphenicol and lincomycin. Antimicrob. Agents Chemother. 41: 2127-2131.
15. Linden, P. K., A. W. Pasculle, R. Manez, D. J. Kramer, J. J. Fung, A. D. Pinna, and S. Kusne. 1996. Differences in outcome for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible Enterococcus faecium. Clin. Infect. Dis. 22:663-670.
16. Mallow, A. G., J. M. A. Bohnen, C. Nohr, N. Christou, and J. Meakins. 1989. Pathogenicity of enterococci in a rat model of fecal peritonitis. J. Infect. Dis. 160:142-145.
17. Mercier, R. C., S. R. Penzak, and M. J. Rybak. 1997. In vitro activities of an investigational quinolone, glycine, glycopeptide, streptogramin, and oxazolidinone tested alone and in combination against vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 41:2573-2575.
18. Nepomuceno, J., M. Case, C. Pachucki, and J. R. Lentino. 1996. In vitro activity of oxazolidinones U-100592 and U-100766 against thirty-five isolates of vancomycin-resistant enterococci, abstr. F231. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
19. Pefanis, A., C. Thauvin-Eliopoulos, J. Holden, G. M. Eliopoulos, M. J. Ferraro, and R. C. Moellering, Jr. 1994. Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscess. Antimicrob. Agents Chemother. 38:252-255.
20. Peng, G. W., R. P. Stryd, S. Murata, M. Igarashi, K. Chiba, H. Aoyama, M. Aoyama, T. Zenki, and N. Ozawa. 1999. Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography. J. Pharm. Biomed. Anal. 20:65-73.
21. Schaadt, R. D., D. H. Batts, P. T. Daley-Yates, S. D. Pawsey, D. J. Stalker, and G. E. Zurenko. 1997. Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid. Diagn. Microbiol. Infect. Dis. 28:201-204.
22. Schülin, T., C. Thauvin-Eliopoulos, R. C. Moellering, Jr., and G. M. Eliopoulos. 1997. In vivo activities of new oxazolidinone antimicrobial agents against enterococci in a rat intra-abdominal abscess model, abstr. B99, p. 44. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Shinabarger, D. L., K. R. Marotti, R. W. Murray, A. H. Lin, E. P. Melchior, S. M. Swaney, D. S. Dunyak, W. F. Demyan, and J. M. Buysse. 1997. Mechanism of action of oxazolidinones: effect of linezolid and eperezolid on translation reactions. Antimicrob. Agents Chemother. 41:2132-2136.
24. Thauvin, C., G. M. Eliopoulos, S. Willey, C. B. Wennersten, and R. C. Moellering, Jr. 1987. Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob, Agents Chemother. 31:139-143.
25. Willey, S. H., R. G. Hindes, G. M. Eliopoulus, and R. C. Moellering, Jr. 1988. Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess. Surg. Gynecol. Obstet. 169:199-202.
26. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.